{
    "organizations": [],
    "uuid": "98f55bf6b7bcf6e004d9a3944a62956d3ba9cb91",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-aldeyra-therapeutics-announces-q1/brief-aldeyra-therapeutics-announces-q1-loss-per-share-0-43-idUSASC0A28U",
    "ord_in_thread": 0,
    "title": "BRIEF-Aldeyra Therapeutics Announces Q1 Loss Per Share $0.43",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - Aldeyra Therapeutics Inc:\n* ALDEYRA THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS\n* Q1 LOSS PER SHARE $0.43 * Q1 EARNINGS PER SHARE VIEW $-0.39 â€” THOMSON REUTERS I/B/E/S\n* QTRLY BASIC AND DILUTED NET LOSS PER SHARE $0.43 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-15T19:44:00.000+03:00",
    "crawled": "2018-05-16T19:02:09.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "aldeyra",
        "therapeutic",
        "inc",
        "aldeyra",
        "therapeutic",
        "announces",
        "first",
        "quarter",
        "financial",
        "result",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "qtrly",
        "basic",
        "diluted",
        "net",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}